Kim MY - Search Results

1

Protective effect of KR-31378 on oxidative stress in cardiac myocytes.

Kim MY, Lee S, Yi KY, Yoo SE, Lee DH, Lim H, Kim HS, Lee SH, Baik EJ, Moon CH, Jung YS. Kim MY, et al. Among authors: kim hs. Arch Pharm Res. 2005 Dec;28(12):1358-64. doi: 10.1007/BF02977902. Arch Pharm Res. 2005. PMID: 16392669

2

KR-31466, a benzopyranylindol analog, attenuates hypoxic injury through mitochondrial K(ATP) channel and protein kinase C activation in heart-derived H9c2 cells.

Jung YS, Jung YS, Kim MY, Kim MH, Lee S, Yi KY, Yoo SE, Lee SH, Baik EJ, Moon CH, Cho JP. Jung YS, et al. Among authors: kim mh, kim my. J Pharmacol Sci. 2003 May;92(1):13-8. doi: 10.1254/jphs.92.13. J Pharmacol Sci. 2003. PMID: 12832850 Free article.

3

KR-31378, a novel benzopyran analog, attenuates hypoxia-induced cell death via mitochondrial KATP channel and protein kinase C-epsilon in heart-derived H9c2 cells.

Moon CH, Kim MY, Kim MJ, Kim MH, Lee S, Yi KY, Yoo SE, Lee DH, Lim H, Kim HS, Lee SH, Baik EJ, Jung YS. Moon CH, et al. Among authors: kim mh, kim hs, kim my, kim mj. Eur J Pharmacol. 2004 Dec 3;506(1):27-35. doi: 10.1016/j.ejphar.2004.10.037. Eur J Pharmacol. 2004. PMID: 15588621

4

KR-32570, a novel Na+/H+ exchanger-1 inhibitor, attenuates hypoxia-induced cell death through inhibition of intracellular Ca2+ overload and mitochondrial death pathway in H9c2 cells.

Kim MJ, Moon CH, Kim MY, Lee S, Yi KY, Yoo SE, Lee SH, Baik EJ, Jung YS. Kim MJ, et al. Among authors: kim my. Eur J Pharmacol. 2005 Nov 21;525(1-3):1-7. doi: 10.1016/j.ejphar.2005.09.043. Epub 2005 Nov 14. Eur J Pharmacol. 2005. PMID: 16289528

5

Pharmacological profile of KR-33028, a highly selective inhibitor of Na+/H+ exchanger.

Jung YS, Kim MY, Kim MJ, Oh KS, Yi KY, Lee S, Yoo SE, Lee BH. Jung YS, et al. Among authors: kim my, kim mj. Eur J Pharmacol. 2006 Mar 27;535(1-3):220-7. doi: 10.1016/j.ejphar.2006.01.041. Epub 2006 Mar 6. Eur J Pharmacol. 2006. PMID: 16516883

6

Methanolic extract of onion (Allium cepa) attenuates ischemia/hypoxia-induced apoptosis in cardiomyocytes via antioxidant effect.

Park S, Kim MY, Lee DH, Lee SH, Baik EJ, Moon CH, Park SW, Ko EY, Oh SR, Jung YS. Park S, et al. Among authors: kim my. Eur J Nutr. 2009 Jun;48(4):235-42. doi: 10.1007/s00394-009-0007-0. Epub 2009 Feb 21. Eur J Nutr. 2009. PMID: 19234663

7

Role of PKC-delta during hypoxia in heart-derived H9c2 cells.

Kim MJ, Moon CH, Kim MY, Kim MH, Lee SH, Baik EJ, Jung YS. Kim MJ, et al. Among authors: kim mh, kim my. Jpn J Physiol. 2004 Aug;54(4):405-14. doi: 10.2170/jjphysiol.54.405. Jpn J Physiol. 2004. PMID: 15631696 Free article.

8

Role of PKCbetaII and PKCdelta in blood-brain barrier permeability during aglycemic hypoxia.

Kim YA, Park SL, Kim MY, Lee SH, Baik EJ, Moon CH, Jung YS. Kim YA, et al. Among authors: kim my. Neurosci Lett. 2010 Jan 14;468(3):254-8. doi: 10.1016/j.neulet.2009.11.007. Epub 2009 Nov 10. Neurosci Lett. 2010. PMID: 19900507

9

Gadd45beta is a novel mediator of cardiomyocyte apoptosis induced by ischaemia/hypoxia.

Kim MY, Seo EJ, Lee DH, Kim EJ, Kim HS, Cho HY, Chung EY, Lee SH, Baik EJ, Moon CH, Jung YS. Kim MY, et al. Among authors: kim ej, kim hs. Cardiovasc Res. 2010 Jul 1;87(1):119-26. doi: 10.1093/cvr/cvq048. Epub 2010 Feb 12. Cardiovasc Res. 2010. PMID: 20154065

10

Protective effect of components isolated from Lindera erythrocarpa against oxidative stress-induced apoptosis of H9c2 cardiomyocytes.

Kim JA, Jung YS, Kim MY, Yang SY, Lee S, Kim YH. Kim JA, et al. Among authors: kim yh, kim my. Phytother Res. 2011 Nov;25(11):1612-7. doi: 10.1002/ptr.3465. Epub 2011 Mar 16. Phytother Res. 2011. PMID: 21412863

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,270 results

Search Page

Filters